Orofacial Pain in Multiple Sclerosis
Launched by VARAZDIN GENERAL HOSPITAL · Aug 29, 2023
Trial Information
Current as of June 09, 2025
Withdrawn
Keywords
ClinConnect Summary
Multiple sclerosis is a chronic autoimmune disease with an unknown mechanism of origin. Although pain is not a typical symptom of multiple sclerosis, it occurs in more than 50% of patients and has significant impact on the quality of life of patients. Pain syndromes that patients with multiple sclerosis initially have characteristics of somatic and nociceptive pain, and later neuropathic, including trigeminal neuralgia, headaches, Lhermitte's syndrome.
Pain is also often associated with anxiety and depression, which occurs in almost one third of patients.
Pain therapy in these patients is...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • multiple scerosis
- • age 18-85 years
- Exclusion Criteria:
- • records with missing data
About Varazdin General Hospital
Varazdin General Hospital is a leading healthcare institution located in Varazdin, Croatia, dedicated to providing comprehensive medical services and advancing clinical research. With a commitment to enhancing patient care through innovative treatment approaches, the hospital actively conducts clinical trials across various therapeutic areas. Leveraging a multidisciplinary team of experienced healthcare professionals, Varazdin General Hospital focuses on ensuring the highest standards of safety and efficacy in its research initiatives, contributing to the development of new medical therapies and improving health outcomes for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Varaždin, , Croatia
Patients applied
Trial Officials
Monika Kocman Panic, MD
Principal Investigator
Varazdin General Hospital, Varazdin, Croatia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported